Core Insights - The China Securities Regulatory Commission (CSRC) has released a report on the status of domestic companies' overseas securities issuance and listing applications as of January 16, 2026, indicating various companies' IPO and full circulation statuses [1] Group 1: Company Listings - Sifang Precision (300468) and Zhenqu Technology have submitted materials for a Hong Kong IPO, which have been accepted by the CSRC [1][2] - Jingze Biopharmaceutical's IPO application for Hong Kong is currently in the status of supplementary materials [1][2] - Vailizhibo-B has received acceptance for its full circulation application from the CSRC [1][2] - Lingbao Gold's full circulation application is also in the status of supplementary materials [1][2] Group 2: Application Details - Lingbao Gold Group's full circulation application was received on January 13, 2026, and is currently in supplementary materials status [2] - Shenzhen Sifang Precision's direct overseas listing application was accepted on January 14, 2026 [2] - Nanjing Vailizhibo Biotechnology's full circulation application was accepted on January 14, 2026 [2] - Beijing Jizhi Technology's full circulation application is in supplementary materials status as of January 16, 2026 [2] - Jingze Biopharmaceutical's direct overseas listing application is in supplementary materials status as of January 16, 2026 [2] - Zhenqu Technology's direct overseas listing application has been accepted [2]